{
    "applicationNumber": "BR 11 2021 000722-9",
    "filingDate": "19/07/2019",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00d5ES FARMAC\u00caUTICAS LIOFILIZADAS PARA TERAPIA G\u00caNICA DE DNA NU",
    "nationalPhaseDate": [
        "15/01/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2019/042702",
        "pctDate": "19/07/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/700,655",
            "priorityDate": "19/07/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2612"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2626"
        }
    ],
    "inventors": [
        "BYEONG SEON CHANG"
    ],
    "holders": [
        135979
    ],
    "ipcCodes": [
        "A61K 47/10",
        "A61K 47/02",
        "A61K 48/00",
        "A61K 47/26",
        "A61P 9/10",
        "A61P 25/02",
        "A61K 9/19"
    ]
}